Volume 16, Number 8—August 2010
Perspective
Hantavirus Infections in Humans and Animals, China
Yong-Zhen Zhang
, Yang Zou, Zhen F. Fu, and Alexander Plyusnin
, Yang Zou, Zhen F. Fu, and Alexander PlyusninTable 3
Inactivated hantavirus vaccines used in China, 1995–2010
| Virus | Cell culture used | Vaccination procedure* | Protection, % |
|---|---|---|---|
| Hantaan | Mongolian gerbil kidney | 3 + 1 | >90 |
| Seoul | Golden hamster kidney | 2 + 1 | >95 |
| Hantaan | Suckling mouse brain | 3 + 1 | >90 |
| Hantaan/Seoul | Mongolian gerbil kidney | 2 + 1 | >95 |
| Hantaan/Seoul | Vero | 2 + 1 | >85† |
*No. doses + no. boosters.
†Seroconversion rate of human hantavirus antibody determined by plaque-reduction neutralization test.
